Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites

Table 2 Quantitative real-time RT-PCR results from Purvalanol B-treated vs control

*Description*	*Gene name*	*Forward primer*	*Reverse primer*	2 ^ΔΔCT *Fold change*	*STD DEV*
Proteasome component C8	PFC0745c	GGTTGTTAAACCAAAGAATG	TGATTTATTCATTAGAAGGAGG	3.2	0.47
Subunit of proteasome activator complex	PFI0370c	AACAAATAAAGATGGGGAAGTATATC	CATGAACAACTTAACCAAGA	2.8	0.37
Proteasome subunit alpha type	PF13_0282	CCAACAGATGCTGAATCG	TTGTAGCAAATGTCCATCAGG	3.6	0.44
Thioredoxin reductase 2	trxr2	CACCTGCTCTTAATAAAGC	GACTTGTTCCATTTATCCACA	5.1	0.84

ISSN: 1475-2875